Cesarean section rate 2003-2017 among HSJ, control and Denmark. by Eva Rydahl (6260771)

Subjects:

Descriptive statistics of variables. by Yanling Li (269030)

Subjects:

Baseline characteristics for HSJ, control and Denmark (without HSJ) in the preintervention period, N = 289.045. by Eva Rydahl (6260771)

Subjects:

Change in maternal characteristics during 2003–2017, HSJ and control. by Eva Rydahl (6260771)

Subjects:

Matched kernel density function diagram. by Yanling Li (269030)

Subjects:

Cesarean section. by Eva Rydahl (6260771)

Subjects:

Matching estimation results of propensity score. by Yanling Li (269030)

Subjects:

Sample balance test. by Yanling Li (269030)

Subjects:

Flow chart of study participants. by Eva Rydahl (6260771)

Subjects:

Timeseries analyses HSJ trend before- and during intervention. by Eva Rydahl (6260771)

Subjects:

Robustness test results. by Yanling Li (269030)

Subjects:

Absolute numbers among CS groups. by Eva Rydahl (6260771)

Subjects:

HSJ and controls stratified by timing for CS and parity. by Eva Rydahl (6260771)

Subjects:

Results of baseline regression. by Yanling Li (269030)

Subjects:

Unmatched kernel density function diagram. by Yanling Li (269030)

Subjects:

Proposed metabolic pathways related to vanadate reduction and alanine production by <i>T</i>. <i>mesophilus</i> VROV1. by Bokyung Kim (622579)

Subjects:

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

Subjects:

Growth and metabolic characteristics of strain VROV1 in vanadate-free (upper panels) and vanadate-containing (lower panels) media. by Bokyung Kim (622579)

Subjects:

Comparison of vanadate reduction by different bacterial strains. by Bokyung Kim (622579)

Subjects:

All data underlying the figures in the main text and supporting information. by Bokyung Kim (622579)

Subjects: